COVID-19 / Coronavirus
The world is taking extraordinary steps to fight and delay the spread of COVID-19. At Schellenberg Wittmer, we have taken the necessary steps to protect the health of our employees, our clients and the wider communities we work and live in. Most of our lawyers and staff now work remotely, but we remain fully available and reachable by phone (the normal phone numbers), email, fax and regular mail.

Deals and Cases

Schellenberg Wittmer advises Oxford Finance on a senior secured credit facility granted to Swiss company ObsEva


Schellenberg Wittmer acted as Swiss legal counsel to Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, in respect of a USD 75 million senior secured credit facility granted to ObsEva SA (NASDAQ: OBSV / SIX: OBSN). ObsEva is a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.

The Schellenberg Wittmer team consisted of partner Philippe Borens (Banking & Finance) and associates Fabio Elsener, Fabio Hurni (both Banking & Finance) and Roland Wild (Tax), who worked in close cooperation with DLA Piper LLP (US), Washington, acting as international counsel to Oxford.


Subscribe to our Newsletter

*Required fields

Monthly selected key topics from our practice areas and sectors, plus Newsflashes on current events.
Monthly email with the latest updates on and summaries of the Swiss Federal Supreme Court's case law in arbitration matters.
A regular look (1 – 2 per year) from a unique M&A perspective on legal changes, economic developments and societal trends in Switzerland.